Gossamer Bio, Inc.
NASDAQ:GOSSBiotechnology
Healthcare
$11.04 +3.24%
+$0.01 today
- Market cap
- $67.52M
- Beta
- 2.04
- P/E (TTM)
- -0.2
- EPS (TTM)
- -$0.77
52W Low $0.11High $3.87
Volume 0.22M
Average 19.76M
Price history
Gossamer Bio, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+261.97%
Period high
$11.94
Period low
$0.14
Latest
$11.04
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 10, 2026 | Nov 10, 2026 | |
| SC 13G/A | Nov 6, 2026 | Nov 6, 2026 | |
| SC 13G | Nov 6, 2026 | Nov 6, 2026 | |
| SC 13D/A | Oct 29, 2026 | Oct 29, 2026 | |
| 8-K | Oct 28, 2026 | Oct 28, 2026 | |
| SC 13D/A | Oct 8, 2026 | Oct 8, 2026 | |
| 8-K | Sep 28, 2026 | Sep 28, 2026 | |
| SC 13D/A | Sep 28, 2026 | Sep 28, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 |
Competitors
Who does Gossamer Bio, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about GOSS's filings, answered from its disclosures.
What is the latest GOSS filing?
The latest filing shown is 10-Q dated Nov 10, 2026.
How many recent filings does GOSS have?
Intrinsic Alpha currently shows 20 recent filings for GOSS.
Continue the stock analysis
Jump to another research area for this company.